| |
| |
|
| Insider
Information: |
Peetz Christopher |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
104,112 |
|
|
Indirect Shares
|
203,470 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$122,930 |
|
|
| Total
Shares |
307,582 |
|
|
| Total
Value |
$122,930 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -19.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tobira Therapeutics Inc |
TBRA |
|
|
0 |
|
0 |
Premium* |
|
|
Alpine Immune Sciences Inc |
ALPN |
Director |
|
0 |
2021-09-23 |
1,900 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
|
2024-02-02 |
104,112 |
2024-02-02 |
201,570 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MIRM |
Mirum Pharmaceuticals, In... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-02 |
4 |
S |
$26.19 |
$157,491 |
D/D |
(6,013) |
104,112 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2024-01-08 |
4 |
S |
$28.03 |
$146,033 |
D/D |
(5,209) |
110,125 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
President and CEO |
• • – |
2023-07-03 |
4 |
S |
$25.65 |
$141,005 |
D/D |
(5,498) |
115,334 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
President and CEO |
• • – |
2023-05-10 |
4 |
A |
$16.92 |
$21,256 |
D/D |
1,256 |
120,832 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
President and CEO |
• • – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
119,576 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-09 |
4 |
S |
$20.62 |
$106,390 |
D/D |
(5,159) |
91,953 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
President and CEO |
• • – |
2022-11-10 |
4 |
A |
$17.05 |
$835 |
D/D |
49 |
69,576 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
President and CEO |
• • – |
2022-05-10 |
4 |
A |
$13.57 |
$20,349 |
D/D |
1,500 |
69,527 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
President and CEO |
• • – |
2022-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
68,027 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
President and CEO |
• • – |
2021-10-01 |
4 |
S |
$19.26 |
$70,708 |
D/D |
(3,672) |
21,027 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
President and CEO |
• • – |
2021-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
21,875 |
24,699 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Director |
– • – |
2021-09-23 |
4/A |
B |
$10.17 |
$19,323 |
I/I |
1,900 |
1,900 |
2.1 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Director |
– • – |
2021-09-23 |
4 |
S |
$10.17 |
$19,323 |
I/I |
(1,900) |
1,900 |
0 |
% |
|
| MIRM |
Mirum Pharmaceuticals, In... |
President and CEO |
• • – |
2021-05-10 |
4 |
A |
$14.62 |
$21,243 |
D/D |
1,453 |
2,824 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
President and CEO |
• • – |
2020-12-23 |
4 |
B |
$18.60 |
$93,480 |
I/I |
5,000 |
201,570 |
2.66 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
President and CEO |
• • – |
2020-11-10 |
4 |
A |
$15.27 |
$20,930 |
D/D |
1,371 |
1,371 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
President and CEO |
• • – |
2019-09-09 |
4 |
B |
$10.90 |
$48,132 |
I/I |
4,320 |
196,570 |
2.66 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
President and CEO |
• • – |
2019-09-06 |
4 |
B |
$10.91 |
$51,806 |
I/I |
4,750 |
192,250 |
2.66 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
President and CEOOfficer |
• • – |
2019-07-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
187,500 |
|
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
